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Abstract.  The myosin light chain  1F/3F  locus con- 
tains two independent promoters,  MLC1F and 
MLC3F, which are differentially activated during 
skeletal muscle development.  Transcription at this lo- 
cus is regulated by a 3' skeletal muscle enhancer ele- 
ment,  which directs correct temporal and tissue- 
specific expression from the MLC1F promoter in 
transgenic mice. To investigate the role of this en- 
hancer in regulation of the MLC3F promoter in vivo, 
we have analyzed reporter gene expression in trans- 
genic mice containing lacZ under transcriptional  con- 
trol of the mouse MLC3F promoter and 3' enhancer 
element.  Our results show that these regulatory ele- 
ments direct strong expression of lacZ in skeletal mus- 
cle; the transgene,  however, is activated 4-5 d before 
the endogenous MLC3F promoter,  at the time of initi- 
ation of MLC1F transcription.  In adult mice, transgene 
activity is downregulated in muscles that have re- 
duced contributions of type 1/13 fibers (soleus and di- 
aphragm).  The rostrocaudal positional gradient of 
transgene expression documented for MLC1F trans- 
genic mice (Donoghue,  M., J.  P. Merlie,  N. Rosen- 
thai,  and J.  R. Sanes.  1991. Proc.  Natl.  Acad.  Sci. 
USA.  88:5847-5851)  is not seen in MLC3F transgenic 
mice. Although MLC3F was previously thought to be 
restricted to skeletal striated muscle, the MLC3F-lacZ 
transgene is expressed in cardiac muscle from 7.5 d of 
development in a spatially restricted manner  in the 
atria and left ventricular compartments,  suggesting that 
transcriptional  differences exist between cardiomyo- 
cytes in left and right compartments of the heart.  We 
show here that transgene-directed  expression of the 
MLC3F promoter reflects low level expression of en- 
dogenous MLC3F transcripts  in the mouse heart. 
URING striated  muscle development,  a dynamic and 
complex pattern of structural gene expression gener- 
ates the diversity of muscle types found in the adult 
vertebrate.  Regulation  of the majority of sarcomeric genes 
is under transcriptional  control mediated by several families 
of regulatory proteins,  including  those of the MyoD and 
MEF2  transcription  factors (Weintraub,  1993;  Yu et al., 
1992). Through  interactions  with cis-acfing  regulatory ele- 
ments, these factors ensure the expression  of specific genes 
whose products are required in particular subsets of cardiac 
and skeletal musculature.  A large number of muscle-specific 
promoter and enhancer elements have been identified as im- 
portant in tissue culture (see Rosenthal,  1989); dissection, 
however,  of the complex spatial  and  temporal  control of 
muscle-specific  gene expression  in vivo,  which  is not re- 
capitulated  in  vitro,  requires  direct  analysis  of putative 
regulatory regions  in transgenic  mice.  Transgenic  studies 
have  demonstrated  the  complexity of cis-acflng  elements 
controlling  the  expression  of  particular  muscle-specific 
genes in different  striated  muscle types, for example,  the 
Address  correspondence to M. Buckingham, CNRS URA 1947, Depart- 
ment of Molecular Biology, Pasteur Institute,  28 Rue du Dr. Roux, 75724 
Paris Cedex  15, France.  Tel: (33)  1-456 88477.  Fax:  (33)  1-456 88963. 
separation  of cardiac  and  skeletal  muscle regulatory ele- 
ments in mice containing  upstream sequences from the des- 
min (Li et al., 1993) and MLC2V (Lee et al., 1992) genes. 
Similarly, transgenic  studies have shown that adult skeletal 
muscle fiber-type diversity is mediated by distinct cis-acting 
elements  that  are  required  for  slow  (Banerjee-Basu  and 
Buonanno,  1993) or fast (Donoghue et al., 1991b; Hallauer 
et al.,  1993) fiber-type expression. 
The diversity of  muscle subtypes is illustrated by the alkali 
myosin light  chain  (MLC)  m  family  composed of three loci 
encoding four isoforms expressed in a developmentally  regu- 
lated pattern in different striated muscle types (Barton and 
Buckingham,  1985). Alkali MLCs comprise two subunits of 
hexameric muscle myosin, and they are implicated in the ve- 
locity of muscle shortening  (Lowey et al., 1993). The MLC 
1F/3F locus encodes the two alkali MLC isoforms found in 
fast skeletal muscle:  MLCIF and 3F differ at the amino ter- 
minal because of the use of two promoters and a differential 
splicing event such that exons 1 and 4 are MLC1F specific, 
and exons 2 and 3 are MLC3F specific (Fig. 1 a in this manu- 
l. Abbreviations  used in this paper: ~-gal, ~-galactosidase;  CAT, chloram- 
phenicol acetyitransferase;  MHC, mysoin heavy chain; MLC, myosin light 
chain; p.c.,  postcoitum;  RT-PCR, reverse transcription PCR. 
© The Rockefeller University Press, 0021-9525/95/04/383/14  $2.00 
The Journal of Cell Biology, Volume 129, Number 2, April 1995 383-396  383 script;  Nabeshima  et al.,  1984;  Periasamy et al.,  1984; 
Robert et al., 1984). Evidence from cell culture experiments 
has shown that the regulation of these two promoter elements 
(which are separated by a  10-kb intron) is largely indepen- 
dent (Strehler et al.,  1985;  Garfinkel and Davidson, 1987; 
Daubas et al.,  1988; Brennan et al.,  1990;  Seidel and Ar- 
nold, 1989; Rosenthal et al., 1990; Pajak et al., 1991). Dur- 
ing myogenesis in vivo, the MLCIF isoform is expressed be- 
fore the MLC3F isoform both in birds and mammals (Hoh, 
1979; Gauthier et al., 1982), such that MLC1F and 3F tran- 
scripts are first detected at 9.5 and 13.5 d postcoitum (p.c.) 
respectively in the mouse (Lyons et al., 1990a); this differen- 
tial regulation has been demonstrated to occur at the level 
of  transcription (Cox and Buckingham, 1992). The late onset 
of MLC3F expression in vivo may be correlated with a de- 
pendence on innervation (Merrifield and Konigsberg, 1987; 
Barton et al., 1989). Furthermore, while MLC1F and 3F iso- 
forms are expressed in fast muscle fibers (type II), the fast 
fiber-type distribution of the two isoforms is distinct, such 
that MLC3F is preferentially associated with glycolytic type 
IIB fibers 0Vada and Pette,  1993;  BottineUi et al.,  1994). 
The MLCIF/3F locus, therefore, provides a model for the 
dissection  of regulatory  elements  controlling  differential 
gene expression during myogenesis. 
An enhancer sequence located 3' to the MLC1F/3F locus 
confers strong muscle-specific expression on the MLC1F 
promoter in muscle cells in culture and in transgenic mice, 
where a chloramphenicol acetyltransferase (CAT) reporter 
gene is activated up to 1,000-fold over background levels ex- 
clusively in skeletal muscle (Donoghue et al., 1988; Rosen- 
thai et al.,  1989).  MLCIF-CAT transgenic mice containing 
the 3' enhancer (IF-CAT-E) initiate transgene expression at 
the  time  of myotome  formation,  when  the  endogenous 
MLC1F gene is first expressed (Grieshammer et al., 1992), 
and CAT expression in adult muscle is specific to fast fibers 
(Donoghue et al., 1991b). Functional binding site motifs for 
transcription factors of  the MyoD and MEF2 families, in ad- 
dition to a homeobox protein target site,  are conserved in 
both rat and human 3' enhancer sequences (Wentworth et al., 
1991;  Rosenthal  et  al.,  1990).  Unexpectedly,  1F-CAT-E 
transgenlc mice show a striking rostrocaudal positional gra- 
dient of CAT expression, such that caudal muscles (e.g., ex- 
tensor digitorum longus) express the transgene at levels 100- 
fold higher than rostral muscles (e.g., masseter, Donoghue 
et al., 1991a).  This graded expression is cell autonomous, 
stably inherited, and correlates with transgene methylation 
in particular muscles along the anterioposterior axis (Dono- 
ghue et al.,  1992a, b).  The sequences responsible for the 
gradient appear to lie within the MLC regulatory elements 
included in the transgene, although there is no gradient of 
endogenous MLC1F expression. It remains unclear (a) how 
the differential regulation of the MLC1F and 3F promoters 
is controlled in the presence of a single enhancer element, 
and (b) whether the cis-acting sequences responsible for the 
caudal-rostral gradient lie in the MLC1F promoter or en- 
hancer element. The experiments described in this paper 
were designed to address these questions. 
We report an analysis of expression from the late activated 
MLC3F promoter in vivo using transgenic mice containing 
the mouse 3F promoter upstream of a lacZ gene (with a nu- 
clear localization signal), and the mouse 3' enhancer down- 
stream of the reporter  gene (construct 3F-nlacZ-E).  Our 
results demonstrate that skeletal muscle-specific expression 
of nlacZ  is  precocious  with  respect  to  the  endogenous 
MLC3F transcript; transgene expression, however, is down- 
regulated postnatally in skeletal muscles with reduced num- 
bers of type lib fibers in the adult (soleus and diaphragm). 
Unlike 1F-CAT-E transgenic mice, no positional gradient of 
rostrocaudal expression is observed at the level of nlacZ tran- 
script or product.  We report the unexpected finding that 
nlacZ is expressed in a restricted subset of cardiac myocytes 
from 7.5 d of development, and we demonstrate that there 
is  low  level  transcriptional activation of the  endogenous 
MLC3F promoter in the heart. This last observation reveals 
a further level of complexity in transcriptional regulation at 
the MLC1F/3F locus, and it leads to a reassessment of the 
overlap in expression patterns between skeletal and cardiac 
striated muscle-specific genes. 
Materials and Methods 
Transgene Construction 
Plasmid pH4 contains the MLC3F promoter and 3F-specific exons plus 
MLC1F-specific exon 4 on a 1.9kb HindIII fragment derived from h phage 
C isolated from the mouse MLC1F/3F locus (Robert et ai., 1984;  see Fig. 
1 a in this manuscript). The HindllI insert of pH4 was subcloned into pBS 
(Stratagene, La Jolla, CA) and modified by extension of MLCIF/3F se- 
quences at the 5' and 3' ends and the introduction of a BgllI site, designed 
for the dual purposes of transgenics and as a homologous recombination 
replacement vector. (a) The BglIl site was introduced at the eighth MLC3F 
codon in exon 2 by site-directed mutaganesis in pBS (Stratagene) to gener- 
ate pLCM6  (using  oligonucleotide  1,  see list at  end of Materials  and 
Methods). pLCM6 was extended by 620 bp at the 3' end by the addition 
of a PCR product generated from BALB/c mouse DNA using oligonucleo- 
tide primers 2 and 3; amplification conditions were 94°C  1 rain, 57°C 1 
rain, and 72°C 3 rain for 25 cycles (Taq DNA polymerase; Perkin-Elmer 
Cetus,  Norwalk,  CT).  The  purified  PCR  product  was  digested  with 
BamHI, subcloned into pBS, verified by DNA sequencing at 5' and 3' ter- 
mini, and subsequently isolated on a BamHI/BspMI fragment for ligation 
with a 260-bp pLCM6 XhoI/BspMI fragment into pLCM6 digested with 
XhoI/BamHI to generate pLCM7.  (b) To extend promoter sequences to 
-2.0 kb, a  1.8-kb PCR amplified fragment (using primers 4 and 5, condi- 
tions as above) was ligated onto the 5' end of pLCM7. This product con- 
tained the expected restriction sites and correct terminal DNA sequence, 
and it was subcloned into pBluescript (Stratagene) on a PstI/EcoRI frag- 
ment, and was subsequently excised as a PstI/ScaI partial fragment for liga- 
tion with the 2.2-kb ScaI/BamHI insert of pLCM7 into PstI/BamHI pre- 
pared pBS  to  generate pLCM8.  (c)  nlacZ-SV-40 poly(A)  (including a 
nuclear localization signal, Kalderon et al., 1984;  details to be published 
elsewhere) was introduced into the unique BglII site of pLCM8 as a 3.1-kb 
NcoI-BamHI fragment that was annealed to a double-stranded oligonucleo- 
tide (annealed oligos 6 and 7) designed to recreate the NcoI site containing 
the nlacZ ATG in frame with MLC3F sequences and to leave a BgllI over- 
hang, generating p3F-nlacZ. The resulting 3F-n/acZ junction was verified 
by DNA sequencing. (d) A 260-bp mouse MLC1F/3F 3' enhancer fragment 
containing the core 173-bp sequence from the rat enhancer (Donoghue et 
ai.,  1988;  Wentworth et  al.,  1991),  and  corresponding to  nucleotides 
361-620 of the rat enhancer (Donoghue et al.,  1988),  was amplified as a 
PCR product using primers 8 and 9, cloned into pBluescript as a BamHI 
fragment, and verified by DNA sequencing. The enhancer was subcloned 
on a BamHI fragment into the unique 3' BamHI site of p3F-nlacZ, in the 
orientation in which the enhancer is found in the MLC1F/3F locus, to gener- 
ate p3F-nlacZ-E. 
Muscle Cell Transfections 
C2/7 skeletal muscle cells were grown under standard culture conditions 
in DME with 20% fetal calf serum for proliferation, or 2 % fetal calf serum 
to induce differentiation. Cells were transfected with 10 ;tg of reporter con- 
struct and 1 ~tg of RSV-luciferase vector per 6-cm dish, using the calcium- 
phosphate method (see Biben et al., 1994).  Cell extracts and luciferase as- 
says were performed as in Biben et al. (1994).  ~-galactosidase assays were 
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with respect to luciferase activities to account for variability in transfection 
efficiency. 
Generation of Transgenic Mice 
The insert of p3F-nlacZ-E was excised as a 7-kb SphI/KpnI fragment, and 
was purified by gel electrophoresis and passage through an Elutip column 
(Schleicher & Schuell, Dassel, Germany). Transgenic mice were generated 
by microinjection of purified 3F-nlacZ-E insert into fertilized (C57BL/6J 
x  SJL) F2 eggs at a concentration of 700 copies per picoliter using stan- 
dard techniques (Hogan et al.,  1986).  Injected eggs were reimplanted into 
pseudopregnant (C57BL/6J  x  CBA) Fl foster mothers. 
Identification of Transgenic Mice 
DNA was prepared from mouse tails (Laird et al., 1991), and was analyzed 
by Southern blot or PCR. For Southern blot analysis 15 ~g of DNA was 
digested with restriction endonucleases in the presence of 100/~g/ml  BSA, 
subjected to electrophoresis, and transferred onto Hybond N + membranes 
(Amersham Corp.,  Arlington  Heights,  IL)  for  hybridization  in  0.5 M 
NaPO4  (pH 7.6),  7%  SDS plus  100/~g/ml  salmon sperm DNA at 65°C 
overnight; filters were washed in 0.Ix SSC, 0.01% SDS at 650C. Hybridiza- 
tion probes were either from the lacZ gene (lkb NcoI/ClaI fragment) or, to 
determine copy number, 5' MLC3F fragments (either 1-kb XbaI/BglII or 
450-bp EcoRI/BglII pLCM6 fragments). For PCR analysis, one primer in 
the proximal MLC3F promoter (10) and one within lacZ (11) were used, 
generating a 1,060-bp product. Amplification conditions were 95°C 1 min, 
62"C 1 rain, and 720C 3 rain, for 25 cycles. Since the 3F-nlacZ-E transgene 
is strongly expressed in adult skeletal muscle, transgenic mice were also 
identified by in toto X-gel staining (see below) of skinned sections of mouse 
tails. 
Analysis of Transgene Expression 
Heterozygous and homozygous transgenic males were crossed with non- 
transgenic females ([C57BL/6J  x  SJL] Fl or CDI). Embryos were dated 
taking 0.5 d p.c. as the day of the vaginal  plug, and they were dissected in 
1x PBS, fixed in 4% paraformaldehyde (for 30 rain to overnight depending 
on the size of  the embryos), rinsed in lx PBS, and colored in X-gel solution 
(X-gal, U. S. Biochemical Corp., Cleveland, OH;  Sanes et ai.,  1986) at 
32"C for periods of 30 rain to overnight. Transgenic embryos and individual 
adult muscles were analyzed by whole-mount microscopy or cryostat sec- 
tions; for the latter,  samples were perfused with 15% sucrose, followed by 
7% gelatin/15% sucrose for 2 h to overnight and frozen in liquid nitrogen 
before cryostat sectioning at -20°C. Sections were stained for/~-gal activ- 
ity,  counterstained for 5  min in  1%  eosin, dehydrated, and mounted in 
Cytoseal mounting medium (Stephens Scientific, Riverdale, NJ). Antibod- 
ies were applied to cryostat sections as described by Tajbakhsh et al. (1994). 
Slow myosin heavy chain antibody (D5)  was supplied by  S.  Schiaffino 
(University of Padua, Italy). 
In Situ Hybridization 
RNA-RNA  hybridization was  performed as  described by  Sassoon and 
Rosenthal (1993);  two 35S-labeled nucleotides (UTP and CTP) were incor- 
porated into the riboprobes. Exposure times were from 5-14 d. The MLC3F 
probe was as described by Lyons et al. (1990a).  A probe within the first 
intron of the mouse MLC1F/3F locus was synthesized from a pBluescript 
clone containing a 7-kb BamI-II/HindlII subfragment of the intron, derived 
from h phage C (Robert et al., 1984).  This plasmid was cut with XbaI and 
a  500-nt  riboprobe complementary to a  region 'x,2 kb upstream of the 
MLC3F transcriptional start site synthesized using T3 RNA polymerase, 
and it was hydrolyzed for 20 rain before hybridization. A  lacZ antisense 
probe was generated by T3  RNA polymerase from ClaI-digested nlacZ- 
SV40 poly(A) in pSK (Stratagene). The RNA product was 2 kb long, and 
it was hydrolyzed for 45 min before hybridization. 
Reverse Transcription Polymerase Chain Reaction 
Total RNA from adult tissue was extracted with guanidium thiocyanate fol- 
lowed by centrifugation on a caesium chloride cushion (Sambrook et al., 
1989).  1/zg of total RNA was mixed with 50 rig p(dN)6  random primers 
(Pharmacia,  Uppsala, Sweden). The mixture was heated for  10  rain at 
70"C, chilled on ice, and adjusted to lx first-strand buffer (Gibco BRL, 
Gaithersburg, MD),  10 mM DTT,  and 0.5 mM dNTPs. RNasin (1 ttl [10 
U];  Amersham)  and  reverse  transcriptase  (1  #1  [200  U]  SuperScript 
RNaseH-; Gibco BRL) were added (final volume =  20 #1). Tubes were in- 
cubated for I h at 42°C, 5 rain at 95°C, spun, and chilled on ice. Four differ- 
ent polymerase chain reactions were performed per cDNA synthesis. 5 #1 
of cDNA solution were amplified in  Ix  Taq buffer (Amersham) with 50 
pmol of each primer,  100/zM dNTPs, and 2  U Taq polymerase (Amer- 
sham). Different numbers (15, 20, and 25) of cycles of amplification were 
carried out to estimate the level of the RNA of interest. Cycle times were 
94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, followed by 60°C for 
2 min and 72°C for 5 min. Oligonucleotide pairs used were: 12 and 13 for 
MLC3F (163-bp product), 14 and 15 for MLC1F (190-bp product), 16 and 
17 for a-cardiac actin (ll5-bp product), 18 and 19 for MRF4 (mouse gene, 
270-bp product), and 20 and 21 for S16 ribosomal protein (102-bp product). 
Samples were separated on 5%  TBE nondenaturing polyacrylamide gels 
that were subsequently electroblotted onto Hybond N + (Amersham) for 
1 h at 15 V using a trans-blot apparatus (Bio Rad Laboratories, Hercules, 
CA). The filter was washed for 10 min in 0.4 M NaOH, rinsed in 2x SSPE 
and heated for 1 h at 80°C. Hybridization was carded out at 65°C as above, 
followed by washes in 0.1×  SSC, 0.1% SDS at 55°C. Hybridization probes 
were MLCIF/3F exon 1 for MLC1F products, MLC1F/3F common exon 5 
for MLC3F products, and a PCR-amplified fragment from the mouse MRF4 
locus  (gift  of M.  Primig,  Pasteur  Institute,  Paris,  France)  for  MRF4 
products. 
Oligonuc~otides 
1  5~TCACTTACCGGAGATCTGGTCAGC3' 
2  5~CATGGATCCACCTGCATAACTGAAGCCCTTGG3' 
3  5'AAGCTTGGATCCACATCGTGTGATGACTTCACC3' 
4  5~CGAATTCTGCAGGTACCTTTCCTCTCTGGATTAGCTATAG3' 
5  5~CCCCGGGAATTCAGTACTTTTATGGTCTTTATCTCTG3' 
6  5~CCTCGAGAGATCTT3' 
7  5~ATGAAGATCTCTCGAGGG3' 
8  5~CGCGGATCCATCGATAACTTCAGCACACTG3' 
9  5~GATGGATCCGGTACCGTGACCAAGGTAACTTG3' 
10  5~AGGAGGAGTGGCAACTGCCCTGTGAAATC3' 
11  5~GGGGATGTGCTGCAAGGCG3' 
12  5~CTGTTTCGCAGCCTAGAACTC3' 
13  5~CTGCATTGGTGGGATTGGTGC3' 
14  5CAGGTTCTTCTGGAGGAGATCC3' 
15  5CTCCTGTTGCTCCTTAGAGAACTCG3' 
16  5~GTGCCTGCCACCAGCGCCAGCCCA3' 
17  5~CACCAAAGCGGTGGTCTCCTCGTC3' 
18  5~TTTCGGATCATTCCAGGGGCCTC3' 
19  5~TCTCTCGCCTTTCATAAAAGCTGGCA3' 
20  5~GGAGCGATTTGCTGGTGTGGA3' 
21  5~CTACCAGGCCTTTGAGATGGA3' 
Results 
To examine the in vivo activity of the MLC3F promoter and 
3'  enhancer,  we  generated  transgenic  mice  containing  a 
nlacZ reporter gene under the control of a  -2kb MLC3F 
promoter and 3' enhancer sequence (3F-nlacZ-E, Fig.  1). 
The construct contains 2 kb 5' and 3' of the MLC3F tran- 
scriptional  start  site,  thus  encompassing  both  MLC3F- 
specific exons (Fig. 1 b). An Escherichia coli lacZ  gene con- 
taining  a  nuclear localization signal  was  cloned in frame 
within the second MLC3F-specific exon such that a fusion 
protein including the first eight MLC3F amino acids is pro- 
duced from a  transcript containing the  entire MLC3F 5' 
UTR. The correct MLC3F splicing pattern is maintained (as 
determined by reverse transcription PCR [RT-PCR], data not 
shown), nlacZ  was selected as a reporter gene for sensitivity 
of both whole-mount and histological assays,  while the in- 
clusion of a nuclear localization signal distinguishes specific 
from nonspecific signals. The 3' enhancer element is a 260- 
bp  mouse sequence, containing the conserved E-box and 
MEF2 motifs demonstrated to be necessary for function of 
the  173-bp minimal rat enhancer fragment (Wentworth et 
al.,  1991); the mouse and rat enhancer DNA sequences are 
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Figure L Structure of the mouse MLCIF/3F locus 
and 3F-n/acZ-E transgene. (a) Diagrammatic rep- 
resentation of the mouse MLCIF/3F locus show- 
ing the distinct IF and 3F promoters that generate 
transcripts  with  differential 5' splicing patterns 
(Periasamy et al., 1984; Nabeshima et al., 1984; 
Robert  et  al.,  1984). The  mouse  3'  enhancer 
element is positioned  1.8 kb downstream of the 
polyadenylation site. The location of the MLCIF 
intronic (A) and MLC3F 5' UTR (B) in situ hybrid- 
ization probes is indicated. The 3F-n/acZ-E trans- 
gene comprises 2 kb of MLC3F sequence on either 
side of the site of initiation  of MLC3F transcription 
(b). The nlacZ reporter gene is placed in frame in 
the second MLC3F-specific exon (exon 3), and a 
260-bp 3' enhancer sequence is included at the 3' 
end of  the transgene (see Materials and Methods). 
MLC3F  constructs  with and without the 3' en- 
hancer were assayed for nlacZ expression by tran- 
sient transfection into C2/7 cells (c). Cells were harvested at myoblast or myotube stages; in myotubes, the relative activity of the construct 
with the enhancer is 60-fold higher than that containing no enhancer (average of five experiments). 
92%  identical over this  core region (data not shown).  In 
C2/7  mouse muscle cells, this 260-bp enhancer sequence 
confers an '~60-fold increase of nlacZ expression from the 
-2 kb MLC3F promoter, specifically in differentiated myo- 
tubes (Fig.  1 c), and is, therefore, an important regulatory 
element for high level transcription from the MLC3F pro- 
moter in tissue culture. Two independent lines of transgenic 
mice containing the 3F-nlacZ-E construct were obtained, 
each containing 5-10 copies of the transgene. Both lines dis- 
play strong B-galactosidase (#-gal) activity in skeletal mus- 
cle such that in adult mice, nlacZ expression is apparent in 
the majority of skeletal muscles. Adjacent nonmuscle tissues 
(including blood vessels, connective tissue, and nerve) are 
negative for transgene expression (Figs. 2 and 3). 
MLC3F-nlacZ-E Expression in Developing 
Skeletal Muscle 
In the developing mouse embryo, the first skeletal muscle 
cells appear in the myotomal compartment of the somites, 
which  differentiates in  a  rostral  to  caudal  gradient  from 
'~8.5 d p.c. (see Buckingham, 1992). 3F-nlacZ-E  transgenic 
mice express nlacZ in the myotome from 9 d p.c., positive 
cells first appearing in rostral somites at about the 18-somite 
stage, initially scattered throughout the myotome. The last 
7-11 formed somites do not express the transgene. Fig. 2 a 
shows a 24-somite mouse embryo (9.5 d p.c.) with transgene 
expression in the myotome of the  13 most rostral somites 
(see also Fig. 2 d). Note that at this stage, the more rostral 
somites express the transgene at a  higher level than more 
caudal somites, consistent with a rostrocaudal gradient of so- 
mite maturation.  Endogenous MLC3F transcripts  are not 
detected at this stage, and they first appear at 13.5 d; MLC1F 
transcripts, in contrast, are detectable from 9.5 d by in situ 
hybridization (Lyons et al.,  1990a). The 3F-nlacZ-E trans- 
gene is, therefore, activated 4 d earlier than the endogenous 
MLC3F promoter in the myotome. 
Transgene expression in the developing limb musculature 
of 3F-nlacZ-E mice is also early with respect to endogenous 
MLC3F transcripts; at 10.5 d p.c., ~gal-positive cells are 
observed in the forelimb bud, and separation into distinct 
premuscle masses is seen by day 11.5 p.c., when three dorsal 
and two ventral groups of positive cells are observed (Fig. 
2 b). In the hindlimb, significant numbers of fl-gal-positive 
cells accumulate from 11.5 d (Fig. 2 b), and distinct premus- 
cle masses are detectable from  12.5  d  p.c.  ~gal-positive 
cells are detected in developing muscle masses surrounding 
the eye from 11.5 d p.c. In addition to expression in skeletal 
muscle,/~-gal-positive cells are also observed in the heart 
throughout development, and transiently in the brain and de- 
veloping ear (from 9 to '~15 d p.c.). Expression at these sites 
is observed in both 3F-nlacZ-E lines. Unexpectedly, endoge- 
nous  MLC3F  transcripts  are  expressed in  the heart  (see 
later);  very low levels of endogenous transcript were de- 
tected by RT-PCR in otic vesicle (after 35 cycles, data not 
shown), but not in brain RNA, at 9.5 d p.c. Transgene ex- 
pression in the developing ear becomes restricted to the dor- 
sal extremity of the endolymphatic duct at 12.5 d. At later 
stages of development, the transgene is clearly expressed in 
the majority of, if not all, skeletal muscle masses throughout 
the embryo (Fig. 2 c). 
Postnatal Downregulation of Transgene Expression in 
Diaphragm and Soleus Muscles 
After birth and during adult life, the 3F-nlacZ-E transgene 
is expressed at high levels in the majority of skeletal muscles. 
Expression of the transgene, however, is downregulated in 
two muscles during postnatal development, such that in adult 
mice, extremely low levels of nlacZ expression are observed 
in the soleus and diaphragm.  These differences reflect the 
particular fiber-type  distribution of  these muscles; both mus- 
cles are adapted for fatigue resistance in adult mice, and they 
lack a significant number of  myosin heavy chain (MHC) type 
liB fast fibers. 
Crural (lower leg) muscles of 3F-n/acZ-E transgenic mice 
express nlacZequivalently at fetal stages (Fig. 3 a); however, 
in adult mice, significantly reduced transgene expression is 
observed in the deep crural muscles, especially in the soleus 
(Fig. 3 b). This decrease in/~-gal activity reflects decreased 
transgene transcription in these muscles as determined by in 
situ hybridization using an antisense lacZ riboprobe (Fig. 3 
e). This pattern of expression appears to reflect the abun- 
dance of fibers containing type I (Fig. 3, c and d) and type 
The Journal of Cell Biology, Volume 129,  1995  386 Figure 2. Transgenic embryos at different stages of development  illustrating  expression of the 3F-n/acZ-E transgene in embryonic and fetal 
skeletal muscles.  (a-c) Whole-mount embryos stained with X-gal; (a) A 24 somite 9.5-d p.o. transgenic embryo (line 2) where the transgene 
is active in the 13 most anterior somites.  In addition  to expression  in the myotome (M), the n/acZ reporter gene is active at this  stage 
in the heart (H), the otic vesicle (OV), and the brain.  (b) An ll.5-d p.o. transgenic  embryo (line  1), showing expression  in developing 
myotomal muscles and the premuscle masses of the limb buds; FL, forelimb,  HL, hindiimb.  (c) A  14.5-d p.o. embryo (line 2) showing 
widespread expression  in skeletal muscles.  A transverse  section through a 10.5-d transgenic  embryo shows ~-galaetosidase  activity in the 
myotomal compartment of the somite (d).  Bar,  100 ttm. 
Spinardi et al. Dominant Negative lntegrin ~  Subunit  387 Figure 3.  3F-n/acZ-E expression in crural and diaphragm muscles. (a) At 17.5 d p.o., B-galactosidase activity is equivalent throughout 
the crural muscles of a 3F-n/acZ-E transgenic embryo, as seen in a cryostat section stained with X-gal. nlacZ activity is downregulated 
in the soleus muscle of an adult (4 mo old) transgenic mouse (b). Reduced time of X-gal coloration reveals that transgene expression is 
also low in the region of the lateral gastrocnemius adjacent to the plantaris muscle (c, asterisk);  both this region and the soleus muscle 
are rich in type I immunopositive fibers, as seen in an adjacent section reacted with MHC I antibody (d). The section in c was photographed 
using an orange filter.  The low expression in adult soleus muscle is at the level of transgene transcription; in situ hybridization with an 
antisense lacZ riboprobe shows reduced activity in  soleus compared to  gastrocnemius muscle (e).  The punctate  signal reflects the 
perinuclear subcellular localization of the n/acZ transcript, and it is comparable to in situ hybridization localization of the CAT transcript 
in 1F-CAT-E transgenic mice (Sassoon and Rosenthal,  1993).  In the diaphragm of a 2-d postnatal mouse, transgene expression remains 
high 0e); after 3 wk, transgene expression levels in the diaphragm decrease (g), remaining highest in nuclei at the center of the fibers 
(Sy, potential synaptic nuclei) and at the myotendinous  junction (Te). G, gastrocnemius; S, soleus; E, extensor digitorum longus; TA, tibialis 
anterior; F, fibula; T, tibia. Bars,  100/~m. 
The Iournal of Cell Biology,  Volume 129, 1995  388 Figure 4.  Expression of the 3F- 
n/acZ-E transgene is not graded 
along the rostroeaudal axis. The 
thoracic region of a  15.5-d p.o. 
transgenic embryo Oine 2)  was 
dissected and stained for B-galac- 
tosidase  activity  (a);  a  whole- 
mount photograph shows a uni- 
form  level of B-gal activity in 
different intercostal muscles (ar- 
rowheads). Similar results were 
obtained at 13.5 d p.c. by X-gal 
coloration of 10-#m cryostat sec- 
tions (b). The level of B-gal mes- 
sage was shown to be uniform in 
different intercostal muscles of a 
16.5-d p.c. embryo by in situ hy- 
bridization with an antisense lacZ 
ribopmbe (c). In situ hybridiza- 
tion with an  antisense MLC3F 
riboprobe  (Fig.  1 a,  probe B) 
confirmed that  the  endogenous 
transcript  is  not  positionally 
graded (d); R, rib. Bars, 250/~m. 
Top is anterior in a-d. 
UA MHC in this muscle (Lewis et al.,  1982; Donoghue et 
al., 1991b; Wigston and English, 1992).  Levels of/3-gal ac- 
tivity are also reduced in the plantaris-adjacent region of the 
lateral gastrocnemius muscle, which in the mouse is also 
particularly rich in type I fibers (Fig. 3 c, asterisk; Hallauer 
et  al.,  1993).  In the  diaphragm,  transgene expression  is 
strong throughout the muscular component in utero, and it 
decreases between 2 and 3 wk after birth (Fig. 3, f and g). 
At this time, it has been shown that the proportion of MHC 
I-expressing fibers is increasing in the rat diaphragm (La- 
Framboise et al.,  1991); the adult mouse diaphragm con- 
tains a mixture of fibers containing type I, IiA, and ILX(D) 
MHC, and it is devoid of fibers containing type liB MHC 
(Zardini and Parry, 1994). Interestingly, nlacZ expression in 
the diaphragm remains highest in a specific subset of nuclei 
localized at synaptic and myotendinous  junctions (Fig. 3 g), 
comparable with endogenous acetylcholine receptor subunit 
expression (Hall and Sanes, 1993; Piette et al., 1993). These 
results support the finding that the nlacZ gene is predomi- 
nantly active in type II fast fibers (with IIB fibers expressing 
the transgene at a higher level than IIA fibers), and they are 
comparable with the observations of  Donoghue et al. (1991b) 
in  1F-CAT-E transgenic mice.  The  3F-nlacZ-E construct, 
therefore, includes the cis-acting DNA sequences which re- 
strict/3-gal expression to fast muscle fibers in vivo. 
Transgene Expression Is Not Graded along the 
Rostrocaudal Axis 
Transgenic mice containing 1.2 kb of rat MLC1F promoter 
sequences upstream of the CAT reporter gene, plus a 900-bp 
rat 3' enhancer fragment downstream of the CAT gene, dis- 
play a  rostrocaudal  gradient of reporter  gene  expression 
which is  distinct from the gradient of somite maturation 
(Donoghue et al., 1991a). To determine whether the regula- 
tory sequences from the MLC1F/3F locus included in the 3F- 
nlacZ-E construct confer a gradient of reporter gene expres- 
sion,/3-gal activity was analyzed in skeletal muscles along 
the body axis of 3F-nlacZ-E mice. 
Apart from the rostrocaudal gradient of somite matura- 
tion, no positional gradient of transgene expression was ob- 
served either during in utero or postnatal development; the 
absence of a gradient of B-gal activity is demonstrated in the 
intercostal muscles at  15.5  d  p.c.  by whole-mount X-gal 
staining (Fig. 4 a), and at 13.5 d p.c.  by X-gal staining of 
cryostat  sections  (Fig.  4  b).  At  these  time  points,  the 
MLC1F-CAT transgene clearly displays a positional gradient 
(Grieshammer et al., 1992). To avoid saturation, B-gal detec- 
tion was carried out under limiting conditions (reduced time 
of coloration). Since/3-gal activity may not directly reflect 
nlacZ transcription (Gundersen et al., 1993),  we confirmed 
by in situ hybridization that the reporter gene transcript is 
expressed at a uniform level in intercostal muscles at 16.5 d 
p.c. (Fig. 4 c). Furthermore, we confirmed that the endoge- 
nous MLC3F transcript, like the MLC1F transcript (Grie- 
shammer et al., 1992), is expressed uniformly along the ros- 
trocaudal axis (Fig. 4 d). These results demonstrate that the 
mouse MLC3F promoter and core 3' enhancer sequence do 
not confer a positional gradient of reporter gene expression 
in transgenic mice. 
Transgene-directed and Endogenous MLC3F 
Expression in Cardiac Muscle 
The MLC3F protein is exclusive to skeletal striated mus- 
culature (Barton and Buckingham, 1985).  It was, therefore, 
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 unexpected to observe strong nlacZ expression in cardiac 
muscle in both lines of 3F-nlacZ-E transgenic mice. In adult 
mice, cardiac expression of  the transgene is regionalized, be- 
ing largely confined to the left ventricle, interventricular sep- 
turn, and atria (Fig. 5, a and b). Transgene expression in the 
left ventricle and interventricular septum is nonuniform, and 
regions of nonexpressing myocardiocytes are observed (Fig. 
5 a); however,  no transmural differences in expression are 
evident. Expression is stronger in the right than left atrium, 
while only occasional positive myocardiocytes are found in 
the right ventricular wall. This pattern of 3F-nlacZ-E trans- 
gene expression was observed by whole-mount X-gal colora- 
tion of isolated transgenic hearts (Fig. 5 a), by histological 
detection of/3-gal activity in cryostat sections of adult hearts 
(Fig. 5 b), and by in situ hybridization to nlacZ transcripts 
in paraffin sections of adult hearts (Fig. 5 c). This pattern of 
3F-nlacZ-E expression is distinct from all other described 
sarcomeric, cytoplasmic, and nuclear cardiac markers in the 
adult myocardium, and, therefore, it defines a previously un- 
described restriction of transcriptional activity in the mouse 
heart. 
The developing heart is the earliest site of transgene ex- 
pression in 3F-nlacZ-E mice. At 7.5 d of development, two 
groups of/3-gal-positive cells are observed in the anterior 
mesoderm.  Transgene expression is regionalized early: at 
8.5 d  p.c., the outflow tract myocardium is/3-gal negative 
(Fig. 5 d). By 9.5 d p.c.,/3-gal expression is localized to the 
regions of presumptive left ventricle and atria (Fig.  5  e); 
significant expression  is  excluded from the  region of the 
presumptive right ventricle, outflow tract, and sinus veno- 
sus.  Right  ventricular  exclusion  of transgene  expression 
therefore  precedes  ventricular  septation;  the  3F-nlacZ-E 
transgene thus provides an early marker for specific sub- 
regions of the developing myocardium. 
The observation that nlacZ is expressed in the heart in two 
lines of 3F-n/acZ-E transgenic mice led us to reexamine ex- 
pression of the endogenous MLC3F gene in cardiac tissue. 
MLC3F protein and accumulated mRNA were not detected 
in cardiac muscle by two-dimensional protein gel or North- 
ern analysis in previous studies (Barton et al., 1985a, b). We 
demonstrate here, however, using RT-PCR, that the endoge- 
nous MLC3F transcript is present in RNA isolated from 
whole adult mouse hearts, although at a significantly lower 
level than in RNA from adult skeletal muscle (Fig. 6, a and 
b). In contrast, a-cardiac actin is expressed at high levels in 
cardiac muscle and low levels in skeletal muscle. The myo- 
genic sequence MRF4, which is specific for skeletal muscle, 
provides a negative control in these experiments (Fig. 6 b). 
The expression of endogenous MLC3F transcripts in the 
four compartments of the adult heart was analyzed (Fig. 6 
c). While the endogenous gene is expressed at higher levels 
in  atrial  than  in  ventricular  myocardium,  no  significant 
differences between left and right ventricles were observed. 
S16 ribosomal protein transcripts are uniformly expressed in 
the four cardiac chambers (Fig. 6 c). 
These findings were confirmed by in situ hybridization; 
endogenous MLC3F transcripts were detected in the heart 
of nontransgenic mice at a time before their appearance in 
developing  skeletal  muscle  (10.5  d  p.c.,  Fig.  7  b).  The 
MLC3F antisense in situ probe is derived from the 5' UTR 
of the MLC3F transcript (Fig. 1 a, probe B), and it does not 
cross-hybridize to other members of the alkali light chain 
gene family (Lyons et al., 1990a).  In agreement with our RT- 
PCR  observations,  the  endogenous  MLC3F  gene  is  ex- 
pressed at higher levels in atrial than ventricular myocardium 
(Fig. 7 b); restriction of detectable levels of  endogenous 3F 
transcript to the atria occurs between 12.5 and 14.5  d p.c. 
(Fig. 7, c and d). The low level of MLC3F ventricular ex- 
pression at later stages precludes the use of in situ hybridiza- 
tion to analyze whether, like the 3F-n/acZ-E transgene, the 
endogenous 3F transcript shows right ventricular exclusion. 
Before 14.5 d, however,  MLC3F expression is regionalized 
in the developing ventricles (Fig. 7 c).  Since the sequence 
complementary to the MLC3F probe lies within the first in- 
tron of the primary MLC1F transcript, the probe can cross- 
hybridize to unprocessed MLC1F transcripts (see Fig. 1 a). 
Using a second probe complementary to unspliced MLC1F 
transcripts  (within the  first intron,  2  kb  upstream  of the 
MLC3F promoter; Fig. 1 a, probe A), we can differentiate 
between unprocessed MLC1F and MLC3F transcripts.  At 
14.5 d p.c., unprocessed MLC1F transcripts are readily de- 
tected in skeletal but not in cardiac muscle (Fig. 7, fand g), 
while the MLC3F probe hybridizes to transcripts in both 
muscle types, showing that the signal observed in the heart 
is specific for the 3F transcription unit (Fig. 7, d and e). Low 
levels of processed MLC1F transcripts were in fact detected 
in adult cardiac muscle by RT-PCR  (Fig. 6 c); these tran- 
scripts,  like MLC3F transcripts,  were  more  abundant  in 
Figure 6. Endogenous MLC3F 
transcript is expressed in the 
heart.  By RT-PCR, MLC3F 
transcripts  are  detected 
in  RNA  isolated from adult 
hearts, although they are pres- 
ent  at a  lower level than  in 
skeletal muscle RNA (a). In 
contrast,  a,  cardiac  actin  is 
represented at a higher level  in 
cardiac than skeletal muscle 
RNA.  PCR  amplifications 
were carried out for 15, 20, and 25 cycles. Cardiac RNA samples are negative for MRF 4, a marker of skeletal muscle cells, after RT-PCR 
and Southern blot hybridization with an MRF 4-specific probe (b). Expression of the MLCIF and 3F transcripts varies among the four 
compartments of the heart (c); both are present at higher levels in atrial than ventricular RNA. S16 ribosomal protein message, in contrast, 
is constant in the four compartments. After 15, 20, and 25 cycles of PCR reaction, products were Southern blot hybridized to either 3F 
or IF probes, and filters were washed  under conditions of  high stringency  (0.1x SSC). L, left; R, right; ~  left ventricle; RV, right ventricle, 
LA, left atria; RA, right atria; S, skeletal muscle; H, cardiac muscle. 
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ever, MLC1F transcripts  could only be detected in the heart 
at  early  stages  of development  (before  10.5 d,  data  not 
shown). 
Discussion 
In this study, we demonstrate that the MLC3F promoter and 
3' enhancer are sufficient to confer strong  muscle-specific 
expression and fast fiber-type distribution  on a  nlacZ  re- 
porter gene in transgenic  mice.  Correct temporal  activa- 
tion of the MLC3F promoter, however, is not observed. We 
have revealed an additional  level of regulation  at this com- 
plex locus, showing that the MLC3F promoter is transcribed 
in the embryonic and adult mouse heart, describing a novel 
pattern of cardiac gene activity. 
The  mouse  MLCIF/3F  3'  enhancer  drives  strong  dif- 
ferentiation-specific  expression  from  the  mouse  MLC3F 
promoter in cultured muscle cells, confirming  in vitro ex- 
periments  carried  out  with  the  rat  gene  (Garfinkel  and 
Davidson,  1987),  and with the human enhancer on the rat 
promoter (Rosenthal  et al.,  1990).  We subsequently ana- 
lyzed the expression  of the MLC3F promoter/3' enhancer 
construct in transgenic mice. During embryogenesis,  the 3F- 
nlacZ-E  transgene  is activated  in muscle ceils at 9 d p.o., 
4-5 d before the endogenous MLC3F transcript  first appears 
(Lyons et al., 1990a). In IF-CAT-E transgenic mice, CAT ex- 
pression is first  detected in the myotome at 9-9.5  d p.c. 
(Grieshammer et al.,  1992),  as is the endogenous MLCIF 
gene.  Reporter gene expression also initiates  at the same 
time in the developing premuscle masses of the limb in IF 
and 3F transgenic mice (11.5 d, this study and Grieshammer 
et al.,  1992).  Thus,  while the 3' enhancer confers correct 
temporal regulation on the MLCIF promoter in vivo, and is 
clearly  an  important  element  for  strong  muscle-specific 
MLC3F transcription  in vitro and in transgenic  mice,  it is 
not sufficient to activate MLC3F expression in vivo at the 
correct time.  Furthermore, late activation  of MLC3F tran- 
scription  does not appear to be the result of developmental 
specificity residing in the proximal 3F promoter.  Our obser- 
vations contrast with findings at the ~-globin locus, where 
a major part of the developmental  specificity of the ~-globin 
genes resides in the proximal  promoters; for example,  fetal 
isoforms are repressed in the adult by factors binding in their 
promoter regions,  the common locus control region subse- 
quently activating distally located adult isoforms  (reviewed 
in Dillon and Grosveld, 1993). 
How the late activation  of MLC3F transcription  is con- 
trolled therefore remains unclear,  although we envisage two 
possible mechanisms:  (a) that the 3' enhancer does not nor- 
mally interact  with the 3F promoter,  and in our transgenic 
mice may overide MLC3F regulatory signals, perhaps in the 
absence of a favored interaction  with the MLC1F promoter, 
which is not included in the construct. Note, however, that 
in the endogenous locus, the MLC1F and 3F promoters are, 
respectively, 25 and 15 kb from the 3' enhancer.  (b) Alterna- 
tively, or in combination with (a), there may be additional 
regulatory elements in the MLCIF/3F locus that are required 
for  late  MLC3F  activation  and  are  not  included  in  the 
construct. We have identified a region of 800 nucleotides in 
the first  intron  of the MLC1F/3F  gene that has myotube- 
specific enhancer activity and interacts  preferentially  with 
the MLC3F promoter in vitro. This intronic region is, there- 
fore, a candidate  sequence that may be required for correct 
MLC3F  expression  in  vivo  fl~lly,  R.,  S.  Alonso,  A. 
Schneider,  S.  Tajbakhsh,  and  M.  Buckingham.  1994.  J. 
Cell.  Biochem.  18D:499  [Abstr.]).  The  analysis  of addi- 
tional transgenic  lines to address this question is underway. 
Early  developmental  misregulation  of the  3F-n/acZ-E 
transgene  is contrasted by later downregulation  in muscle 
types known to contain low levels of MLC3F protein.  In 
adult transgenic mice, low ~-gal levels are seen in the soleus 
and diaphragm,  although both muscles express the transgene 
at high levels in utero. Other muscles, such as the tibialis an- 
terior,  continue to express high levels of/~-gal in the adult. 
These changes correlate with the development of adult fiber- 
type diversity. Biochemical, physiological,  and histological 
properties vary between muscle fibers,  which can be sub- 
divided on the basis of  which MHC isoform they express (see 
Pette and Staron, 1990; Schiaffino and Reggiani,  1994). Fi- 
ber type content varies among different muscles, such that 
mouse soleus,  for example, contains roughly equal propor- 
tions of slow (type I) and fast (type II, A>X) fibers (Lewis 
et al., 1982; Donoghue et al., 1991b), while the tibialis an- 
terior contains >90% fast fibers (Donoghue et al.,  1991b). 
The region of the gastrocnemius  laterally  adjacent to the 
plantaris muscle, where the transgene is also downregulated, 
is, like the soleus,  rich in fibers containing  type I and HA 
MHC, and lacks glycolytic fibers containing type lIB MHC. 
Similarly, the diaphragm  is rich in types I, HA, and IIX(D) 
fibers,  and  devoid  of type I/B fibers  (Zardinl  and  Parry, 
1994). These data suggest that (a) the 3F-n/acZ-E transgene 
is expressed preferentially  in type II (fast)  fibers,  and (b) 
nlacZ expression is higher in a subset of type II fibers (most 
likely fiB). The 3' enhancer and MLC3F proximal promoter 
sequences included  in the transgene  are therefore sufficient 
to confer fast fiber-type specificity. Similar results were ob- 
tained by Donoghue et al.  (1991b) in IF-CAT-E transgenie 
mice, which express CAT at a higher level in fast than slow 
fibers; furthermore,  CAT levels vary among type II fiber sub- 
types in the order IIB>IIX(D)>HA. The core enhancer ele- 
ment common to 1F-CAT-E and 3F-n/acZ-E transgenic mice 
may therefore be involved in selective fiber-type expression. 
Hallauer et al.  (1993) also reported a HB>RA>I pattern of 
expression of a fast quail troponin I-/acZ construct in trans- 
genie mice; in this case, the endogenous mouse gene was ex- 
pressed evenly in all fast (type ID fibers. In contrast, a lacZ 
reporter gene under the control of the Pgk-1 promoter is ex- 
pressed in fast fibers containing  HA or IIX MHC, but not in 
type l/B fibers or slow type I MHC fibers (McBurney et al., 
1994).  Distinct cis-regulatory  elements are thus likely  to 
direct  gene  expression  in  different  fast  fiber  types  (see 
Schiaffino and Reggiani,  1994). We are currently comparing 
the pattern of transcription  of the endogenous MLC3F gene 
with that  of the 3F-n/acZ-E  transgene  in particular  fiber 
types at a more detailed cellular level. 
The low level of transgene expression observed in the adult 
diaphragm  in  3F-n/acZ-E  mice  (>90%  RA/X(D)  fibers, 
Zardini and Parry,  1994) is consistent with our observations 
in crural muscles. Interestingly, a subpopulation of nuclei in 
diaphragm  fibers  continues to express elevated  transgene 
levels at focal synaptic and terminal myotendinous junctions, 
both regions being marked by elevated acetylcholinesterase 
activity (in the myotendinous junction at 20% of levels at the 
Spinardi et al. Dominant Negative  lntegrin {34 Subunit  393 neuromuscular junction, see Schmalbruch, 1985).  The 3F- 
nlacZ-E transgene marker can therefore be added to the list 
of synaptic membrane, basal laminal, and cytoskeletal pro- 
teins that are concentrated at synaptic sites (Hall and Sanes, 
1993). At the present time, there is no evidence for elevated 
endogenous 3F protein at these sites, but this requires further 
investigation, as  does  identification of the  cis-acting  se- 
quences in the MLC3F promoter or 3' enhancer responsible 
for this expression pattern. 
1F-CAT-E transgenic mice exhibit a rostrocaudal gradient 
of reporter gene expression, which suggests that the trans- 
gene responds to intrinsic differences in positional informa- 
tion along the body axis  (Donoghue et al.,  1991a).  The 
endogenous MLC1F gene, however,  is  not graded in ex- 
pression, yet the CAT gradient has been shown to be di- 
rected  by  sequences  contained  within  the  MLC-derived 
fragments. It is not dependent on the reporter gene since a 
gradient of expression is observed when CAT is substituted 
by either the acetylcholine receptor 3,-subunit eDNA (Do- 
noghue et al.,  1991a) or lacZ (Donoghue, M., J.  Merlie, 
and J.  Sanes,  personal communication). 3F-n/acZ-E mice 
provide a second transgenic mouse strain containing regula- 
tory sequences derived from the 1F/3F locus, and it was thus 
of interest to determine whether the nlacZ gene is expressed 
in a  positionally graded manner in these mice.  We have 
demonstrated in this study that/3-gal protein and mRNA lev- 
els are not positionaUy graded in the intercostal muscles of 
3F-nlacZ-E  transgenic embryos, at a  stage when the CAT 
gradient is evident in 1F-CAT-E mice. Our results show that 
the MLC3F promoter and core 3' enhancer do not confer a 
positional gradient of reporter gene expression in transgenic 
mice, and they suggest that the cis-acting sequences respon- 
sible for the gradient in 1F-CAT-E mice lie outside the core 
3' enhancer. 
The MLC1F and 3F proteins axe restricted to skeletal stri- 
ated muscle (see Barton and Buckingham, 1985). Two other 
mouse alkali MLC isoforms are expressed in both skeletal 
and cardiac muscle: MLC1V in slow skeletal fibers and adult 
ventricle, and MLC1A in embryonic and fetal skeletal mus- 
cle and adult atria (Barton et al.,  1985a, b). We have now 
demonstrated that both transgene directed and endogenous 
MLC3F transcription occurs  in  cardiac muscle.  Cardiac 
MLC3F expression is likely to depend on regulatory se- 
quences in the MLC3F promoter region, since, in contrast 
to the 3F-n/acZ-E transgene, the 3' enhancer does not drive 
CAT expression in 1F-CAT-E transgenic mouse hearts (Ro- 
senthal et al., 1989). Furthermore, MLC3F transgenic mice 
lacking the 3' enhancer express a high level of nlacZ in the 
heart (Kelly,  R., S. Alonso, and M. Buckingham, unpub- 
lished observations). 
3F-n/acZ-E transgene expression follows a previously un- 
documented pattern of cardiac gene expression. As early as 
8.5 d of development, at the tubular heart stage, transgene 
expression is regionalized such that the outflow tract and a 
region of the common ventricle (future right ventricle) are 
nonexpressing. The 3F-n/acZ-E transgene thus provides an 
early marker for positional specification in the developing 
mouse heart, and it should help to address the question of 
whether such spatial restriction arises from distinct lineages 
of committed cardiac precursors, or via positional cues. The 
two major cardiac alkali myosin light chain genes axe, in con- 
trast to the 3F-n/acZ-E transgene, widely expressed in the 
myocardium  at early stages, and only later in embryogenesis 
do they become restricted to atrial or ventriculax  compart- 
ments (Lyons et al., 1990b). MLC2V, however, the ventricu- 
lax regulatory myosin light chain, shows earlier regionaliza- 
tion to the ventficulax compartment Coy ll d, O'Brien et al., 
1993). While many cardiac genes have been documented to 
be expressed in atria or ventricles, few have been described 
which  demonstrate  left/right  compartmental  differences. 
Two examples of  which we axe aware are (a) atrial natriuretic 
peptide,  for which low level  ventricular expression in the 
adult (1% of atrial expression levels)  is stronger in the left 
than right ventricle (Gardner et al., 1986); (b) muscle crea- 
tine kinase (MCK), which shows transient left/right asym- 
metry with transcripts first appearing in the wall of the right 
ventricle of the 12.5-d mouse heart; by 15.5 d, MCK tran- 
scripts axe expressed at a high level in all cardiac myocytes 
(Lyons, 1994). Our results suggest that transcriptional differ- 
ences exist between right and left ventriculax compartments, 
and that such differences precede septation (complete by 13 
d) and associated secondary physiological constraints. Fur- 
thermore, left/right transcriptional differences are mediated 
by sequences included in the 3F-n/acZ-E construct. 
By both RT-PCR and in situ hybridization we have shown 
that our observations in transgenic mice reflect low level 
transcription of the endogenous MLC3F gene in the mouse 
heart. MLC3F expression is compartmentalized, with higher 
transcript levels in atrial than ventriculax RNA. Endogenous 
MLC3F transcripts in embryonic hearts show some ventric- 
ulax regionalization, but in adult hearts, in contrast to nlacZ 
expression in transgenic mice, no left/right asymmetry is 
evident; the cause of  this difference remains unclear. The low 
level of MLC3F transcription in the heart is likely to explain 
why cardiac MLC3F expression was not previously observed 
(Barton and Buckingham, 1985). Although the low level of 
MLC1F protein has been reported in embryonic cardiac mus- 
cle cells in the chick (Obinata et al., 1983), there is no evi- 
dence for the presence of 1F or 3F MLC isoforms in mam- 
malian cardiac muscle (Whalen et al., 1982). Reexamination 
of MLC protein isoforms present in the adult heart on silver- 
stained two-dimensional gels revealed no trace of MLC1F or 
MLC3F proteins either in whole mouse heart or in left and 
right  atrial  and  ventricular protein  preparations  (Buffer- 
Browne, G., V. Mouly, E  Edom, R. Kelly, S. Alonso, and 
M. Buckingham, unpublished data). Therefore, it seems un- 
likely that MLC3F transcription in the heart is of functional 
importance since MLC3F protein,  if present, is at an ex- 
tremely low level compared with that of the major cardiac 
alkali MLC isoforms, MLC1A and MLCIV. It is possible that 
cardiac MLC3F transcripts axe subject to posttranscriptional 
control. This would not be without precedent: Gorza et al. 
(1993) have demonstrated that rat cardiac troponin I mRNA 
accumulates in the ventricle of developing rat hearts from 
day 1  I, whereas the protein is not detected in the ventricles 
before day 18. 
While a number of cardiac muscle isoforms axe transiently 
expressed  during  skeletal muscle development (including 
MLC1A and o~-caxdiac actin),  there are also examples of 
skeletal muscle protein isoforms that are transiently expressed 
in the developing heart: these include a-skeletal actin (Sas- 
soon et al., 1988) and MLC2F (Faerman and Shani, 1993). 
Our results extend the known overlap in genes activated at 
early stages of both cardiac and skeletal myogenesis, and 
The Journal of Cell Biology,  Volume 129, 1995  394 they  suggest  that  transcriptional  activation  requirements 
for both striated muscle types are shared by many muscle- 
specific genes. 
Note added in proof.  Similar results showing MLC3F expression in the 
heart have been obtained by Michael McGrew and Nadia Rosenthal (Car- 
diovascular Research Center,  Massachusetts General  Hospital,  Charles- 
town, MA), according to a personal communication. 
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